Each patients response to the medication is unique, and regular follow-up visits are necessary to ensure the medication is working effectively and that any potential side effects are addressed
Do a patch test before first use to check for reactions
The medication works by increasing the release of insulin, a hormone that helps lower blood sugar
3.2 GLP-1RAs in psoriatic arthritis The therapeutic landscape of PsA is currently dominated by targeted agents that inhibit key inflammatory pathways, including TNF inhibitors (e.g., adalimumab, etanercept), IL17 inhibitors (e.g., secukinumab, ixekizumab), IL-23 inhibitors (e.g., guselkumab, risankizumab), and Janus kinase (JAK) inhibitors such as upadacitinib and tofacitinib (62)
Jan 14 2021;13(1)doi:10.3390/nu13010218
Studies demonstrate thymosin beta-4 accelerates healing of various surgical wounds by promoting cell movement and organizing tissue remodeling